Bisacodyl, a diphenylmethane derivative, is a commonly used over the counter stimulant laxative for occasional constipation. Both bisacodyl and picosulfate are metabolized to the same active metabolite bis-(p-hydroxyphenyl)-pyridyl-2-methane (BHPM).
Bisacodyl was patented on 25 September 1956 but has been used as a laxative since 1952.
Bisacodyl is indicated to relieve occasional constipation and irregularity.
Florida Clinical Research Group, Clearwater, Florida, United States
Gastroenterology Research Consultants of Greater Cincinnati, Cincinnati, Ohio, United States
Investigational site, Hollywood, Florida, United States
Louisiana Research Center LLC, Shreveport, Louisiana, United States
Indiana University Hospital, Indianapolis, Indiana, United States
Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States
Gastroenterology Services, Downers Grove, Illinois, United States
Cooper University Hospital, Camden, New Jersey, United States
Brooke Army Medical Center, San Antonio, Texas, United States
122.56.44011 Boehringer Ingelheim Investigational Site, Bedworth, United Kingdom
122.56.44032 Boehringer Ingelheim Investigational Site, Addlestone, United Kingdom
122.56.44018 Boehringer Ingelheim Investigational Site, Ash Vale, Aldershot, United Kingdom
Department of Surgery, Triemli Hospital, Zurich, Switzerland, Zurich, Switzerland
Hotel Dieu Hospital, Kingston, Ontario, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.